AstraZeneca Annual Report and Form 20-F Information 2008

Remuneration Committee remit and key activities during the year

A copy of the Remuneration Committee’s remit is available on the Company’s website, astrazeneca.com, or by request from the Company Secretary.

KEY ACTIVITIES DURING THE YEAR

The Remuneration Committee considered the following matters, amongst other things, during 2008.

• The terms of senior executives’ packages on appointment, promotion and termination.
• As part of a benchmarking of the Committee’s activities and policies, a review of the Company’s compliance with institutional investor guidelines.
• A review of guiding principles that inform the Company’s approach to total reward arrangements to ensure that the remuneration strategy supports the business strategy.
• Assessment of financial performance against earnings per share (EPS) targets to determine the level of payment of bonuses for 2007 and set EPS targets for 2008.
• Prepared, reviewed and approved the Directors’ Remuneration Report.
• Approved the awards made under the Group’s main incentive plans (Performance Share Plan and Share Option Plan) to Senior Executive Team (SET) members and other selected participants.
• Developed long-term incentive (LTI) arrangements for a number of subsidiary businesses which contribute towards specific Group strategic and commercial objectives.
• Reviewed LTI arrangements in the light of age discrimination legislation.
• Proposed remuneration and incentive arrangements to support senior level recruitment.

Back to the top